Sizing a feared exposure against the discount it caused, separating price from value over five years, and reading price rises that customers never notice.
1. Size the feared exposure, then compare it to the discount it produced
The repeatable method
- Name the fear precisely — not "sentiment", but the specific balance-sheet item the market is worried about.
- Find that item as a percentage of assets, revenue or earnings.
- Measure the drawdown the fear has caused.
- Compare the two. If the whole company has fallen as though the exposure were total, the mispricing is arithmetic rather than a judgement call.
- Then check the quality of the exposure itself, so you are not just arguing about size when the small piece is genuinely bad.
Here: KKR — "The stock is down nearly 21% this year due to fears around private credit. But KKR's actual direct lending exposure is just 21% of assets. This looks like an overreaction and a potential opportunity." The whole firm was marked down as though a fifth of it were the whole of it.
Watch for
- The remaining 79% being correlated with the feared 21% — an asset manager's fundraising slows when its credit book sours, even if the book is small.
- Exposure percentages measured on AUM rather than on earnings, which can understate the profit contribution.
2. Check whether an asset manager's capital can actually leave
The repeatable method
- For any fee-earning business, split assets under management into redeemable, locked-up and permanent.
- Find the lockup lengths and the share of AUM behind them.
- Identify permanent sources — insurance balance sheets, listed vehicles, evergreen funds.
- The fee base that survives a 40% drawdown is the one worth capitalising; the rest is cyclical.
- Then read fundraising as the growth line and lockups as the durability line, separately.
Here: KKR — Global Atlantic supplies $321bn of permanent capital, "money that never leaves", and "most KKR funds have lockup periods of 7-12 years. That means 92% of their AUM is basically locked in… they don't have to worry about investors panicking and pulling their money out during a market crash." Growth is measured separately: $129bn raised in 2025, $115bn+ a year expected.
Watch for
- Insurance-funded permanent capital bringing its own risk — the liabilities are permanent too.
- Performance fees (carry) being counted as recurring. Only the management fee on locked capital really is.
3. Chart price against revenue over five years to isolate multiple compression
The repeatable method
- Pick a window long enough to span a re-rating — five years works.
- Plot the share price and a fundamental line (revenue, EPS or free cash flow per share) rebased to 100.
- The divergence between them is the change in multiple, with no valuation model required.
- If fundamentals doubled while the price rose 20%, you have measured a de-rating exactly, and the question becomes whether the starting multiple was the anomaly.
- Apply the same chart to the whole portfolio to tell a stock-picking problem from a style drawdown.
Here: MSCI — "MSCI got quite expensive starting in 2019. As a result, the stock has been moving sideways for the past 5 years.
The price is up 20% during that time, even though revenue has almost doubled." The same divergence, aggregated, is the entire argument of the
2 August portfolio update and its owner's-earnings-versus-price framing.
Watch for
- The starting point being the distortion. A stock that "got quite expensive starting in 2019" was re-rating up then; five years of nothing may just be the round trip.
- Revenue doubling through acquisition rather than organically — per-share figures avoid this.
4. Look for pricing power in components that are a rounding error to the buyer
The repeatable method
- Work out what the product costs as a share of the customer's total spend on the end item.
- If it is tiny, and the item cannot function without it, price increases are unlikely to be contested.
- Confirm the customer has no legal alternative supplier — sole-source certification, patent, or regulatory approval.
- Check the realised increase rate over several years; a consistent 5-6% is the signature.
- Ask what would make the customer start caring: a big enough cumulative increase, a certified alternative, or a regulator.
Here: TDG — "Because their parts cost a tiny fraction of what a plane costs,
airlines barely notice the bill. So TransDigm raises prices 5-6% every single year." Backed by sole-source status on 90% of revenue and a 27.4% annual compound since the 2006 IPO. The same mechanism, inverted, drives
HEI in
Part II: HEICO's percentage discount grows in cash terms every time an OEM raises price.
Watch for
- Customers organising. Airlines have complained about aftermarket pricing before, and regulators occasionally listen.
- The cumulative effect: 5-6% a year doubles the price in twelve years, which is when "barely notice" stops being true.
5. Rank switching costs by what has to be re-learned, not by what has to be re-bought
The repeatable method
- Ask what a customer would have to relearn to switch — not what they would have to repurchase.
- Check where the learning happens. Skills acquired during professional training are the stickiest, because the decision was made before the customer had a budget.
- Add the risk dimension: in medicine, aviation and security, switching carries a safety cost, not just an inconvenience one.
- Look for a renewal mechanism — each new cohort of trainees resets the lock-in for another career.
Here: SYK — "Surgeons learn on Stryker tools during their training and stick with them for their careers. Switching brands means retraining, lower efficiency, and
higher risk for patients." The comparable case in
Part II is
FTNT: switching security vendors means "leaving yourself wide open to attacks in the process."
Watch for
- Hospital purchasing consolidating and overriding individual surgeon preference.
- A hardware head start (Mako's three years) being confused with a permanent one — measure it in installations, which is what is done here.
6. For a small-cap serial acquirer, the moat is deal flow, not product
The repeatable method
- Establish the typical target size and ask who else is bidding for it.
- If the targets are too small to move a large acquirer's needle, the buyer faces no competition and pays low multiples.
- Check the operating model: decentralised, owner-retained management is what makes sellers choose you over a private equity auction.
- Check the funding: interest coverage and leverage decide whether the machine keeps running through a downturn.
- Check alignment: a controlling family or founder is the usual reason the discipline survives.
Here: LIFCO-B.ST — "Lifco targets tiny market leaders in specialized niches… These companies are too small for larger players to even look at." Funding: interest coverage 10.0x, debt-to-equity 0.3x. Alignment: "Carl Bennet owns 50% of the company. The chairman has over half his wealth tied to Lifco's success." Result: revenue +13% and EPS +16% a year for a decade — "a page right out of CSU.TO's playbook."
Watch for
- Size killing the model. The same argument used against Constellation in favour of Topicus applies to any acquirer that outgrows its target pool.
- Entry multiples: quality serial acquirers rarely get cheap in absolute terms. The target here is the stock's own six-year floor (20x), not a bargain.
7. When buying a holding company, ask what the discount does not protect you from
The repeatable method
- Split the underlying portfolio into listed and unlisted.
- The listed share moves with the market daily; the discount does not cushion it, it only sets your entry.
- The unlisted share is marked by the manager, so it is smoother — and less reliable.
- Set the entry as a discount level (price-to-book or price-to-NAV), and hold the expectation of volatility separately.
Here: INVE-B.ST — "
Roughly 70% of the portfolio consists of publicly traded securities. When global markets sell off, Investor AB's net asset value will decline with them. It's a great long-term bet, but you should expect some volatility along the way." Entry: 0.9x book = ~281 SEK against 372 SEK — the same discount discipline used on
3i Group and
HgCapital Trust.
Watch for
- A holding-company discount that never closes. Family control is what makes the capital allocation good and the discount permanent, at the same time.
- Family control cutting both ways — no activist can force a re-rating either.
8. Apply your own balance-sheet standard to every candidate, including the ones you admire
The repeatable method
- Write down the balance-sheet metrics you require — interest coverage, net debt to EBITDA, debt to equity.
- Report them for every candidate, not only the ones that pass.
- When a business model is explicitly debt-funded, say what the leverage is and what happens to it in a downturn.
- If you make an exception, say that you are making one and why.
Here: LIFCO-B.ST gets its numbers — "interest coverage sits at 10.0x and debt-to-equity at 0.3x."
TDG does not: its model is described approvingly as "
a Private Equity model in a public stock — TransDigm uses debt to buy more niche businesses, then use the massive cash flow from those companies to pay it off and go shopping again", with no leverage figure given. The
portfolio scorecard published a week earlier leads on interest coverage of 39.5x against the index's 6.8x.
Watch for
- Track records that were produced by leverage in a falling-rate era being extrapolated into a different one — 27.4% a year since 2006 spans exactly that period.
- The asymmetry in your own write-ups: which candidates get a balance-sheet paragraph and which get a compounding statistic instead.
Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.